发明名称 |
FGF-18 COMPOUND DOSING REGIMEN |
摘要 |
The present invention provides a new dosing regimen for administration of FGF18 in the treatment of a cartilage disorder, such as osteoarthritis or cartilage injury. Specifically provided is a preferred treatment scheme comprising administrations every 2 weeks of an FGF-18 compound per treatment cycle. The new dosing regimen can include the co-adminsitration of a anti-inflammatory drug.. |
申请公布号 |
CA2938793(A1) |
申请公布日期 |
2015.08.27 |
申请号 |
CA20152938793 |
申请日期 |
2015.02.20 |
申请人 |
MERCK PATENT GMBH |
发明人 |
LADEL, CHRISTOPH H.;GUEHRING, HANS |
分类号 |
A61K38/18;A61P19/02 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|